Drugs prices are rising, but not as fast as you may think

Cara Livernois | | Health Exec | Policy & Regulations

An article by Forbes discusses healthcare costs, drug prices, government interventions and policy reform.

Read the full article below:

The Really Tough Questions About Healthcare Costs

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Study ranks US health system dead last among wealthy nations
Landmark opioid trial in Baltimore set to begin; Johnson & Johnson settles to avoid jury
Coalition of 86 healthcare groups calls for change to Affordable Care Act rule
FDA issues recall on infusion pump parts due to risk of uncontrollable drug flow
Social media ads led 200K patients to unwittingly drop their insurance
AMA study shows four pharmacy benefit managers control 70% of the market

Around the web

Cardiovascular Business
Cath lab techs and nurses see new normal with post-COVID pay

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Cardiovascular Business
Merit Medical to purchase Cook Medical’s lead management portfolio for $210M

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

Cardiovascular Business
Abiomed, Biosense Webster, Cerenovus now all known as Johnson & Johnson MedTech

These companies were already part of the Johnson & Johnson family, but they had still retained their previous brand names. Now, each one is officially going by Johnson & Johnson MedTech. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup